W Matta

No ORCID on file · 4 papers in corpus · active 1986-1990

Study types

  • article 2
  • book-chapter 2

Condition tags

  • endometriosis 4
book-chapter 1990
A Phase III Clinical Trial of Buserelin versus Danazol in the Treatment of Endometriosis
·doi:10.1007/978-94-009-2169-6_5
book-chapter 1990
A Phase III Clinical Trial Of Buserelin Versus Danazol in the Treatment of Endometriosis
·doi:10.1007/978-94-009-0721-8_5
article 1988
REVERSIBLE TRABECULAR BONE DENSITY LOSS FOLLOWING INDUCED HYPO‐OESTROGENISM WITH THE GnRH ANALOGUE BUSERELIN IN PREMENOPAUSAL WOMEN
Clinical endocrinology ·doi:10.1111/j.1365-2265.1988.tb00248.x

Thirteen premenopausal women who each received 400 micrograms three times daily of intranasal buserelin for 6 months as treatment for endometriosis participated in this study. Cortical bone mineral content (BMC) in the mid-shaft of the righ…

article 1986
Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens.
Clinical reproduction and fertility

Buserelin [D-Ser(TBU)6-des Gly NH2(10) LHRH ethylamide], an LHRH agonist, was administered intranasally at two dose levels, 200 micrograms t.d.s or 300 micrograms t.d.s., to 20 women with proven endometriosis, many with recurrent disease. B…